conjugated bile acids
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02871882)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- conjugated bile acids
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05314374 | Phase 1 | Apr 30, 2023 | Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| NCT02871882 | Phase 2 | Aug 1, 2016 | Mayo Clinic, Satiogen Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 2 | 2 | 2 | 2016 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2023 |
| Satiogen Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1